The observation that DMT1 upregulation correlates with iron accumulation in the SN of PD patients (Salazar et al. 2008) has prompted us to investigate the role of the DMT1 transporter in brain metal accumulation and neurodegeneration. Here, SLC11A2 is linked to Parkinson disease.